Our results demonstrate that CARIR-expressing macrophages have increased phagocytotic activity against PD-L1+ cancer cells in vitro and that systemic delivery of CARIR-expressing myeloid cells inhibit tumor growth in vivo. The gene discussed is CD274; the disease is neoplasm.